Key points are not available for this paper at this time.
In this work, we design an asymmetric hetero-trimetallic single-atom catalyst with ZnN 3 CoN 3 FeN 2 S active catalytic sites to enhance the oxygen reaction performances.
Chen et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: